Jacobs Levy Equity Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q4 | – | Sell |
-3,470
| Closed | -$235K | – | 1106 |
|
2019
Q3 | $235K | Sell |
3,470
-64,258
| -95% | -$4.35M | ﹤0.01% | 815 |
|
2019
Q2 | $3.94M | Sell |
67,728
-76,409
| -53% | -$4.45M | 0.05% | 391 |
|
2019
Q1 | $10.1M | Buy |
144,137
+72,270
| +101% | +$5.06M | 0.15% | 182 |
|
2018
Q4 | $4.63M | Sell |
71,867
-73,626
| -51% | -$4.74M | 0.08% | 279 |
|
2018
Q3 | $10.2M | Buy |
145,493
+23,533
| +19% | +$1.65M | 0.14% | 178 |
|
2018
Q2 | $6.15M | Sell |
121,960
-290
| -0.2% | -$14.6K | 0.1% | 254 |
|
2018
Q1 | $3.83M | Buy |
122,250
+10,160
| +9% | +$318K | 0.06% | 333 |
|
2017
Q4 | $3.83M | Sell |
112,090
-14,382
| -11% | -$492K | 0.07% | 321 |
|
2017
Q3 | $4.06M | Buy |
126,472
+23,492
| +23% | +$754K | 0.08% | 286 |
|
2017
Q2 | $3.35M | Sell |
102,980
-2,450
| -2% | -$79.7K | 0.07% | 313 |
|
2017
Q1 | $3.32M | Buy |
105,430
+760
| +0.7% | +$23.9K | 0.07% | 320 |
|
2016
Q4 | $3.08M | Buy |
104,670
+40,900
| +64% | +$1.2M | 0.06% | 335 |
|
2016
Q3 | $1.84M | Buy |
63,770
+20,367
| +47% | +$589K | 0.03% | 433 |
|
2016
Q2 | $1.12M | Sell |
43,403
-5,500
| -11% | -$142K | 0.02% | 557 |
|
2016
Q1 | $1.21M | Sell |
48,903
-20,980
| -30% | -$520K | 0.03% | 525 |
|
2015
Q4 | $2.46M | Buy |
69,883
+2,410
| +4% | +$84.8K | 0.05% | 305 |
|
2015
Q3 | $1.43M | Buy |
67,473
+16,780
| +33% | +$355K | 0.03% | 422 |
|
2015
Q2 | $1.41M | Buy |
50,693
+11,180
| +28% | +$311K | 0.03% | 422 |
|
2015
Q1 | $1.21M | Sell |
39,513
-3,380
| -8% | -$103K | 0.02% | 441 |
|
2014
Q4 | $1.37M | Sell |
42,893
-910
| -2% | -$29.1K | 0.02% | 445 |
|
2014
Q3 | $1.24M | Buy |
+43,803
| New | +$1.24M | 0.02% | 460 |
|
2014
Q1 | – | Sell |
-8,280
| Closed | -$242K | – | 1056 |
|
2013
Q4 | $242K | Buy |
+8,280
| New | +$242K | ﹤0.01% | 844 |
|